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Abstract  The  ex  utero  intrapartum  treatment  (EXIT)  procedure  consists  of  partial  externaliza-
tion of  the  fetus  from  the  uterine  cavity  during  delivery,  allowing  the  maintenance  of  placental
circulation.  It  is  indicated  in  the  presence  of  congenital  malformation  when  difﬁculty  in  fetal
airway access  is  anticipated,  allowing  it  to  be  ensured  by  direct  laryngoscopy,  bronchoscopy,
tracheostomy,  or  surgical  intervention.  Anesthesia  for  EXIT  procedure  has  several  special  fea-
tures, such  as  the  appropriate  uterine  relaxation,  maintenance  of  maternal  blood  pressure,
fetal airway  establishment,  and  maintenance  of  postpartum  uterine  contraction.  The  anesthe-
siologist should  be  prepared  for  the  anesthetic  particularities  of  this  procedure  in  order  to
contribute to  a  favorable  outcome  for  the  mother  and  particularly  the  fetus.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
PALAVRAS-CHAVE
Procedimento  EXIT;
Tratamento
extraútero
Anestesia  para  procedimento  EXIT  (tratamento  extraútero  intraparto)  em
malformac¸ão  congênita  cervical  --  um  desaﬁo  para  o  anestesiologista
Resumo  O  procedimento  EXIT  (tratamento  extraútero  intraparto)  consiste  na  exteriorizac¸ãointraparto;
Malformac¸ão
congênita  cervical;
Anestesia
parcial do  feto  da  cavidade  uterina  durante  o  parto  para  permitir  a  manutenc¸ão  da  circulac¸ão
fetoplacentária.  Está  indicado  na  presenc¸a  de  malformac¸ões  congênitas  em  que  se  antecipa  a
diﬁculdade  no  acesso  da  via  aérea  fetal  e  permite  que  essa  seja  assegurada  por  laringoscopia
direta,  broncoscopia,  traqueostomia  ou  intervenc¸ão  cirúrgica.  A  anestesia  para  procedimento
EXIT apresenta  várias  particularidades.  O  relaxamento  uterino  adequado,  a  manutenc¸ão  da
 estabelecimento  de  via  aérea  fetal  e  a  manutenc¸ão  da  contrac¸ãopressão arterial  materna,  o∗ Corresponding author.
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uterina  pós-parto  são  alguns  exemplos.  O  anestesiologista  deve  estar  preparado  para  as  partic-
ularidades  anestésicas  desse  procedimento,  de  modo  a  contribuir  para  um  desfecho  favorável
para a  mãe  e  particularmente  para  o  feto.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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cackground and objectives
ecent  advances  in  prenatal  diagnosis  allow  early  detec-
ion  of  defects  responsible  for  fetal  airway  obstruction  that
eneﬁt  from  intrapartum  treatment.1
The  EXIT  procedure  (ex  utero  intrapartum  treatment)  is
ndicated  in  the  presence  of  these  situations.  It  is  performed
uring  cesarean  section  and  after  partial  externalization
f  the  fetus  from  uterine  cavity  and  consists  of  the  feto-
lacental  circulation  maintenance  until  the  fetal  airway  is
ecured.2
It  was  originally  described  to  reverse  the  tracheal  occlu-
ion  performed  in  utero  treatment  of  severe  congenital
iaphragmatic  hernia.  Currently,  it  is  used  in  situations
here  the  fetus  has  airway  obstruction  at  the  end  of  ges-
ation.  The  procedure  is  usually  scheduled  after  the  35th
eek  of  pregnancy  and  prematurity  is  not  considered  a
ontraindication.3
The  anesthetic  technique  during  the  EXIT  procedure
differs  from  a  normal  cesarean  section  and  has  some  pecu-
liarities.
This  article  describes  a  case  in  which  the  EXIT  procedure
was  performed  successfully  in  fetus  with  prenatal  diagno-
sis  of  submandibular  cystic  lymphangioma  and  discusses  the
anesthetic  technique  applied  with  a  brief  literature  review.
Case report
A  female  patient,  35  years  old,  gravida  1/to  0,  with  39  weeks
of  pregnancy,  ASA  II  due  to  allergic  rhinitis,  presenting  with
fetus  with  right  cervical  mass  diagnosed  by  prenatal  ultra-
sound  at  31  weeks  of  pregnancy  (Fig.  1).
At  36  weeks,  a  magnetic  resonance  imaging  (MRI)  test  was
performed  and  conﬁrmed  an  expansive  lesion  in  the  soft  tis-
sues  of  hemiface  and  proximal  portion  of  the  submandibular
region  and  right  cervical  with  55  mm  ×  50  mm  ×  53  mm,Figure  1  Prenatal  ultrasound.
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for  additional  tocolytic  drugs.
After  cutting  the  umbilical  cord,  oxytocin  (10  U)  was
administered  at  uterine  myometrium,  sevoﬂurane  wasFigure  2  Fetal  MRI.
associated  with  tongue  protrusion/macroglossia  with  a  diag-
nosis  compatible  with  cystic  lymphangioma  (Fig.  2).
Elective  cesarean  section  was  scheduled  with  EXIT  proce-
dure  by  a  multidisciplinary  team  of  neonatologists,  pediatric
surgeons,  obstetricians,  anesthesiologists,  and  nurses.
The  chosen  anesthetic  technique  was  balanced  general
anesthesia  with  epidural  catheter  placement  for  postopera-
tive  analgesia.
In  the  operating  room,  the  initial  maternal  monitoring
was  performed  with  pulse  oximetry,  ECG,  and  noninvasive
blood  pressure,  and  the  mother  was  positioned  in  the  left
lateral  position  for  epidural  catheter  placement.  Anesthe-
sia  was  applied  to  the  skin  with  1%  lidocaine  (2  mL)  and  the
identiﬁcation  of  the  epidural  with  air  was  initiated  by  the
median  approach  in  L3--L4.  The  epidural  space  was  identi-
ﬁed  at  5.5  cm  of  the  skin,  and  the  epidural  catheter  was
inserted  up  to  11  cm.  Subsequently,  a  test  dose  was  admin-
istered  with  2%  lidocaine  2  mL  (40  mg)  and  the  catheter  was
ﬁxed.  Afterwards,  the  pregnant  woman  was  placed  in  a
supine  position  with  the  uterus  displaced  to  the  left  with
pad  and  lateralization  of  the  table.
Before  induction  of  anesthesia,  catheterization  of  radial
artery  for  invasive  monitoring  of  blood  pressure  and  two  18-
G  peripheral  venous  accesses  were  performed.
Afterwards,  the  remaining  monitoring  with  invasive  blood
pressure,  capnography,  anesthetic  gas  analyzer,  and  hourly
dieresis  were  performed.
Face  mask  oxygenation  was  performed  with  100%  oxy-
gen  for  5  min  and  midazolam  (2  mg)  was  administered.  Rapid
sequence  induction  was  initiated  with  thiopental  300  mg
(4  mg/kg),  rocuronium  40  mg  (0.6  mg/kg),  fentanyl  0.05  mg,
Sellick  maneuver,  and  tracheal  intubation  with  a  7.5-cuffed
tube.  General  anesthesia  was  maintained  with  2--3%  sevoﬂu-
rane  and  remifentanil  (0.1--0.5  g/kg/min).  After  induction
of  anesthesia,  midazolam  1  mg,  fentanyl  0.1  mg,  and  rocuro-
nium  10  mg  were  given.  For  the  maintenance  of  maternal
systolic  blood  pressure  above  100--120  mmHg  it  was  neces-
sary  to  administer  ephedrine  5  mg  and  hydroxyethyl  starch
500  mL.
F
eFigure  3  Nasotracheal  intubation  of  the  newborn.
The  time  elapsed  between  the  induction  of  anesthesia
nd  hysterotomy  was  15  min.
After  the  hysterectomy,  the  head,  trunk,  and  upper
imbs  of  the  fetus  were  externalized,  preserving  the  uter-
ne  volume  and  fetoplacental  circulation.  The  fetal  tracheal
ntubation  was  achieved  under  direct  laryngoscopy,  with  a
.5  uncuffed  tube,  4  min  after  hysterectomy.  The  correct
ositioning  of  the  nasotracheal  tube  was  conﬁrmed,  and  we
roceeded  to  the  clamping  and  cutting  of  the  umbilical  cord
Figs.  3  and  4).
During  the  procedure,  uterine  relaxation  obtained  with
--3%  sevoﬂurane  was  satisfactory  and  there  was  no  needigure  4  Evidence  of  macroglossia  and  right  submandibular
dema.
5r
u
l
a
o
r
a
r
i
t
C
P
o
t
m
b
t
a
a
c
a
c
c
a
c
t
c
t
t
r
c
u
d
c
m
p
a
h
o
i
o
t
u
g
o
a
s
r
p
a
t
i
a
o
f
(
n
c
t
i
r
o
b
r
f
s
o
o
s
p
y
d
t
t
m
r
l
s
w
w
s
c
r
a
o
t
t
I
i
a
m
d
s
d
w
p
p
n
a
t
f32  
educed  to  0.8%,  and  remifentanil  infusion  was  discontin-
ed.  There  was  adequate  uterine  contraction.
Total  volume  of  ﬂuids  infused  was  1.500  mL  of  crystal-
oid  and  500  mL  of  colloids.  The  estimated  bleeding  was
pproximately  800  mL  and  there  was  no  need  for  transfusion
f  blood  products.  At  the  end  of  the  procedure,  the  neu-
omuscular  blockade  was  reversed  with  neostigmine  2  mg
nd  atropine  1  mg,  and  the  patient  was  extubated  after  full
eversal  of  the  blockade.
The  newborn  was  transferred  to  the  pediatric  hospital,
ntubated,  mechanically  ventilated,  and  sedated  with  fen-
anyl  infusion.  The  newborn  transport  was  uneventful.
onclusions
renatal  diagnosis  of  fetal  malformation  in  the  cervical  or
ral  region  with  obstruction  of  the  upper  airway  is  essential
o  reduce  perinatal  morbidity  and  mortality.3,4 It  allows  the
aternal--fetal  monitoring  during  pregnancy  and  deﬁne  the
est  approach  to  be  undertaken  during  delivery.3
EXIT  is  indicated  in  the  presence  of  congenital  malforma-
ions  in  which  difﬁculty  in  fetal  airway  access  is  anticipated
nd  allows  its  patency  by  direct  laryngoscopy  or  ﬁberoptic
nd  orotracheal  intubation  or  tracheostomy  before  fetopla-
ental  separation.1,5 It  is  deﬁned  as  a  procedure  performed
fter  partial  externalization  of  the  fetus  from  the  uterine
avity,  with  uterine  volume  maintenance  and  fetoplacental
irculation,  and  ensures  the  fetal  oxygenation  during  airway
ccess.6,7
Anesthesia  for  this  procedure  differs  from  a  conventional
esarean-section  and  general  anesthesia  is  the  preferred
echnique.1,2 Deep  uterine  relaxation,  uteroplacental  cir-
ulation  preservation,  anesthesia,  and  fetal  immobility  are
he  main  goals  of  this  procedure.1,2,7,8
Uterine  relaxation  is  critical  to  prevent  uterine  con-
ractions  and  placental  separation.2 Several  authors  have
ecommended  the  administration  of  inhaled  anesthetics  in
oncentrations  not  below  2  MAC,  which,  in  addition  to
terine  relaxation,  are  responsible  for  maternal  and  fetal
eep  anesthesia.  In  the  event  of  poor  uterine  relaxation,  it
an  be  achieved  with  tocolytic  drugs,  such  as  terbutaline,
agnesium  sulfate,  or  nitroglycerin.  Nitroglycerin  has  ideal
harmacokinetic  characteristics,  such  as  its  short  half-life
nd  high  potency,  but  it  may  have  adverse  effects,  such  as
ypotension.2,6 It  is  used  in  intravenous  bolus  of  50--100  g
r  by  continuous  infusion  of  10--20  g/kg/min.6
Maintenance  of  the  fetoplacental  circulation  is  also
mportant  during  EXIT,  as  it  provides  adequate  fetal
xygenation.6 Fetal  oxygenation  may  be  compromised  in
he  presence  of  maternal  hypotension,  which  may  occur
pon  administration  of  tocolytic  drugs,  such  as  nitro-
lycerin.  Aggressive  ﬂuid  resuscitation  and  administration
f  vasopressors  and  inotropic  drugs,  such  as  dobut-
mine,  are  critical  to  maintain  the  maternal  hemodynamic
tability.1,2 Invasive  blood  pressure  monitoring  is  strongly
ecommended  for  adequate  control  of  hemodynamic
arameters.1,7,8Fetal  anesthesia  and  immobility  are  essential  for  a  safe
nd  effective  airway  management,  which  occurs  by  the
ransplacental  passage  of  anesthetic  drugs  administered
n  the  maternal  circulation.  When  ineffective,  it  can  be
C
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ssured  by  intravenous  or  intramuscular  administration  of
pioids  or  neuromuscular  relaxants  drugs  directly  on  the
etus.1,8
In  situations  where  general  anesthesia  is  contraindicated
difﬁcult  airway  or  high  risk  of  malignant  hyperthermia),
euraxial  anesthesia  should  be  considered.1,9 In  these  cir-
umstances,  uterine  relaxation  should  be  obtained  with
ocolytic  drugs,  as  described  above.
The  main  intraoperative  and  postoperative  complication
s  bleeding,  which  is  usually  associated  with  uterine  atony,
elated  to  the  administration  of  high  doses  of  tocolitic  drugs
r  procedure  duration.1,5,8,10
In  our  case,  the  chosen  anesthetic  technique  was  the
alanced  general  anesthesia  because  it  is  preferable  to  neu-
axial  anesthesia  in  this  kind  of  procedure,  and  we  opted
or  epidural  catheter  placement  for  postoperative  analge-
ia.  Uterine  relaxation  was  achieved  with  the  administration
f  2--3%  sevoﬂurane,  and  the  additional  administration
f  tocolitic  drugs  was  not  required.  Systolic  blood  pres-
ure  over  100--120  mmHg,  essential  for  proper  placental
erfusion,  was  maintained  with  ephedrine  and  hydrox-
ethyl  starch,  and  there  was  no  need  to  use  inotropic
rugs.
The  fetal  immobility  occurred  by  the  transfer  of  anes-
hetic  agents  administered  in  the  maternal  circulation
hrough  the  placenta,  and  it  was  not  necessary  to  supple-
ent  the  fetus  anesthesia  with  opioids  or  neuromuscular
elaxants.  In  our  case,  the  fetus  did  not  react  to  the  direct
aryngoscopy  maneuvers,  which  strongly  contributed  to  the
uccess  of  tracheal  intubation.  After  securing  the  fetal  air-
ay,  we  proceeded  to  the  full  externalization  of  the  fetus,
ith  umbilical  cord  clamping  and  uterine  relaxation  rever-
al.
The  period  of  time  between  hysterectomy  and  umbilical
ord  clamping  was  approximately  5  min,  a  shorter  time  in
elation  to  other  cases  in  the  literature.6 This  seems  to  be
 factor  of  great  importance  for  fetal  well-being  at  the  end
f  the  EXIT  procedure.6,11
To  prevent  uterine  atony,  the  high  inhalational  anes-
hetic  concentrations  should  be  discontinued  after  clamping
he  umbilical  cord  and  oxytocin  should  be  administered.
n  the  case,  uterine  contraction  was  achieved  after  reduc-
ng  the  inspired  concentration  of  sevoﬂurane  to  0.8%  and
fter  administration  of  oxytocin  (10  U)  at  the  uterine
yometrium.  The  estimated  bleeding  during  the  proce-
ure  was  similar  to  that  of  a  conventional  cesarean
ection.
This  intervention  success  was  due  not  only  to  the  early
iagnosis  of  malformation  responsible  for  the  fetal  air-
ay  obstruction,  but  fundamentally  to  the  planning  of  the
rocedure  by  a  multidisciplinary  team  of  neonatologists,
ediatric  surgeons,  obstetricians,  anesthesiologists,  and
urses.
Anesthesiologists  should  be  aware  and  prepared  for  the
nesthetic  particularities  of  this  procedure  in  order  to  con-
ribute  to  a  favorable  outcome  for  the  mother  and  especially
or  the  fetus.onﬂicts of  interest
he  authors  declare  no  conﬂicts  of  interest.
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